查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1548169

全球栓塞治療市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Embolotherapy Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

全球栓塞治療市場需求預計將從 2023 年的 48.7 億美元達到近 106.8 億美元的市場規模，2024-2032 年研究期間複合年成長率為 9.12%。

栓塞療法是一種透過引入栓塞劑來閉塞血管並治療血管疾病的醫療技術。這種微創手術涉及將線圈、顆粒或液體製劑注射到血管中，以阻止或減少流向目標區域的血流。它可以治療子宮肌瘤、某些類型的腫瘤和動靜脈畸形等疾病。這種醫療技術旨在透過選擇性阻斷血液供應來縮小或消除異常生長、減少出血並緩解症狀。該技術使用成像引導來確保栓塞材料的精確傳遞。它提供了比傳統手術侵入性更小的選擇，具有恢復時間更短和併發症風險更低等優點，使其成為當代介入放射學的寶貴財富。

市場動態

由於適合栓塞治療的疾病（例如子宮肌瘤、動靜脈畸形（AVM）和某些腫瘤）的盛行率不斷增加，栓塞治療市場正在擴大。這些疾病的發生率不斷上升，以及人們越來越意識到栓塞療法是一種有效的治療選擇，推動了市場的成長。技術進步為市場提供了巨大的機會。栓塞劑的創新，包括開發更有效和生物相容性材料，可增強治療效果並擴大可透過栓塞療法解決的病症範圍。即時透視和 3D 成像等先進成像技術進一步提高了栓塞治療程序的精確度和安全性，推動了其採用。

微創治療的趨勢也促進了市場的成長。栓塞療法為傳統手術方法提供了一種侵入性較小的替代方案，從而縮短了恢復時間並降低了併發症發生率。隨著患者偏好轉向微創選擇，對栓塞治療手術的需求預計將會上升。此外，擴大新興市場的醫療服務範圍也帶來了成長機會。隨著這些地區醫療保健基礎設施的改善和介入放射學技術意識的提高，在先進治療方法的普及和醫療保健投資的增加的推動下，栓塞療法的採用可能會成長。然而，高成本和潛在的程序風險可能會抑制市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球栓塞治療市場的每個細分市場進行了包容性評估。栓塞治療產業的成長和趨勢為本研究提供了整體方法。

市場區隔

栓塞療法市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按產品分類

  • 栓塞劑
  • 微球
  • 栓塞彈簧圈（可拆式彈簧圈、可推彈簧圈）
  • 液態栓塞劑
  • 栓塞系統
  • 可拆卸氣球
  • 支援設備
  • 微導管
  • 導絲

按疾病適應症

  • 癌症
  • 肝癌
  • 腎癌
  • 其他癌症
  • 周圍血管疾病
  • 神經系統疾病
  • 腦動脈瘤
  • 腦動靜脈畸形和瘻管
  • 胃腸道疾病
  • 泌尿系統和腎臟疾病

按程序分析

  • 經導管動脈栓塞術
  • 經導管動脈放射栓塞/選擇性內放射治療
  • 經動脈化療栓塞術

透過最終用戶分析

  • 醫院和診所
  • 門診手術中心
  • 其他最終用戶

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲栓塞治療市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。栓塞治療市場的主要參與者包括 Merit Medical Systems、Boston Scientific Corporation、Medtronic Plc、Meril Life Sciences Pvt.。這部分包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：栓塞治療 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按產品分類的市場吸引力分析
    • 依疾病適應症進行的市場吸引力分析
    • 透過程式分析進行市場吸引力分析
    • 最終用戶分析的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球栓塞治療市場分析：按產品

  • 概述（按產品）
  • 按產品分類的歷史和預測資料分析
  • 栓塞劑
  • 微球
  • 栓塞彈簧圈（可拆式彈簧圈、可推彈簧圈）
  • 液態栓塞劑
  • 栓塞系統
  • 可拆卸氣球
  • 支援設備
  • 微導管
  • 導絲

第 6 章：全球栓塞治療市場分析：依疾病適應症

  • 按疾病適應症概述
  • 按疾病跡象進行歷史和預測數據分析
  • 癌症
  • 肝癌
  • 腎癌
  • 其他癌症
  • 周圍血管疾病
  • 神經系統疾病
  • 腦動脈瘤
  • 腦動靜脈畸形和瘻管
  • 胃腸道疾病
  • 泌尿系統和腎臟疾病

第 7 章：全球栓塞治療市場分析：按程序分析

  • 按程序分析概述
  • 透過程式分析進行歷史和預測資料分析
  • 經導管動脈栓塞術
  • 經導管動脈放射栓塞/選擇性內放射治療
  • 經動脈化療栓塞術

第 8 章：全球栓塞治療市場分析：按最終用戶分析

  • 最終用戶分析概述
  • 透過最終用戶分析進行歷史和預測數據分析
  • 醫院和診所
  • 門診手術中心
  • 其他最終用戶

第 9 章：全球栓塞治療市場分析：依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 10 章：栓塞治療公司的競爭格局

  • 栓塞治療市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 11 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Merit Medical Systems
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Boston Scientific Corporation
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Medtronic Plc
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Meril Life Sciences Pvt. Ltd
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

Product Code: VMR112115503

The global demand for Embolotherapy Market is presumed to reach the market size of nearly USD 10.68 Billion by 2032 from USD 4.87 Billion in 2023 with a CAGR of 9.12% under the study period 2024-2032.

Embolotherapy is a medical technique used to occlude blood vessels and treat vascular conditions by introducing embolic agents. This minimally invasive procedure involves injecting coils, particles, or liquid agents into blood vessels to block or reduce blood flow to targeted areas. It manages conditions like uterine fibroids, certain types of tumors, and arteriovenous malformations. This medical technique aims to shrink or eliminate abnormal growths, reduce bleeding, and alleviate symptoms by selectively blocking the blood supply. This technique uses imaging guidance to ensure precise delivery of the embolic material. It provides a less invasive option than traditional surgery, offering advantages like shorter recovery time and a lower risk of complications, making it a valuable asset in contemporary interventional radiology.

MARKET DYNAMICS

The embolotherapy market is expanding due to the increasing prevalence of conditions amenable to embolotherapy, such as uterine fibroids, arteriovenous malformations (AVMs), and certain tumors. The rising incidence of these conditions and the growing awareness of embolotherapy as an effective treatment option fuel market growth. Technological advancements provide substantial opportunities for the market. Innovations in embolic agents, including developing more effective and biocompatible materials, enhance treatment outcomes and expand the range of conditions that can be addressed through embolotherapy. Advanced imaging technologies, such as real-time fluoroscopy and 3D imaging, further improve the precision and safety of embolotherapy procedures, driving adoption.

The trend towards minimally invasive treatments is also contributing to market growth. Embolotherapy offers a less invasive alternative to traditional surgical approaches, leading to reduced recovery times and lower complication rates. As patient preference shifts towards minimally invasive options, the demand for embolotherapy procedures is expected to rise. Additionally, expanding healthcare access in emerging markets presents growth opportunities. As healthcare infrastructure improves and awareness of interventional radiology techniques increases in these regions, adopting embolo therapy is likely to grow, driven by enhanced access to advanced treatments and increasing healthcare investment. However, high costs and potential procedural risks can restrain market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Embolotherapy. The growth and trends of Embolotherapy industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Embolotherapy market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Embolic agents
  • Microspheres
  • Embolic coils (Detachable Coils, Pushable Coils)
  • Liquid Embolic Agents
  • Embolic Plug Systems
  • Detachable Balloons
  • Support Devices
  • Microcatheters
  • Guidewires

By Disease Indication

  • Cancer
  • Liver Cancer
  • Kidney Cancer
  • Other Cancers
  • Peripheral Vascular Diseases
  • Neurological Diseases
  • Cerebral Aneurysm
  • Cerebral Arteriovenous Malformations and Fistulas
  • Gastrointestinal Disorders
  • Urological and Nephrological Disorders

By Procedure Analysis

  • Transcatheter Arterial Embolization
  • Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
  • Transarterial Chemoembolization

By End User Analysis

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Other End Users

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Embolotherapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Embolotherapy market include Merit Medical Systems, Boston Scientific Corporation, Medtronic Plc, Meril Life Sciences Pvt. Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. EMBOLOTHERAPY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Disease Indication
    • 3.7.3 Market Attractiveness Analysis By Procedure Analysis
    • 3.7.4 Market Attractiveness Analysis By End User Analysis
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL EMBOLOTHERAPY MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Embolic agents Historic and Forecast Sales By Regions
  • 5.4. Microspheres Historic and Forecast Sales By Regions
  • 5.5. Embolic coils (Detachable Coils, Pushable Coils) Historic and Forecast Sales By Regions
  • 5.6. Liquid Embolic Agents Historic and Forecast Sales By Regions
  • 5.7. Embolic Plug Systems Historic and Forecast Sales By Regions
  • 5.8. Detachable Balloons Historic and Forecast Sales By Regions
  • 5.9. Support Devices Historic and Forecast Sales By Regions
  • 5.10. Microcatheters Historic and Forecast Sales By Regions
  • 5.11. Guidewires Historic and Forecast Sales By Regions

6. GLOBAL EMBOLOTHERAPY MARKET ANALYSIS BY DISEASE INDICATION

  • 6.1. Overview By Disease Indication
  • 6.2. Historical and Forecast Data Analysis By Disease Indication
  • 6.3. Cancer Historic and Forecast Sales By Regions
  • 6.4. Liver Cancer Historic and Forecast Sales By Regions
  • 6.5. Kidney Cancer Historic and Forecast Sales By Regions
  • 6.6. Other Cancers Historic and Forecast Sales By Regions
  • 6.7. Peripheral Vascular Diseases Historic and Forecast Sales By Regions
  • 6.8. Neurological Diseases Historic and Forecast Sales By Regions
  • 6.9. Cerebral Aneurysm Historic and Forecast Sales By Regions
  • 6.10. Cerebral Arteriovenous Malformations and Fistulas Historic and Forecast Sales By Regions
  • 6.11. Gastrointestinal Disorders Historic and Forecast Sales By Regions
  • 6.12. Urological and Nephrological Disorders Historic and Forecast Sales By Regions

7. GLOBAL EMBOLOTHERAPY MARKET ANALYSIS BY PROCEDURE ANALYSIS

  • 7.1. Overview By Procedure Analysis
  • 7.2. Historical and Forecast Data Analysis By Procedure Analysis
  • 7.3. Transcatheter Arterial Embolization Historic and Forecast Sales By Regions
  • 7.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy Historic and Forecast Sales By Regions
  • 7.5. Transarterial Chemoembolization Historic and Forecast Sales By Regions

8. GLOBAL EMBOLOTHERAPY MARKET ANALYSIS BY END USER ANALYSIS

  • 8.1. Overview By End User Analysis
  • 8.2. Historical and Forecast Data Analysis By End User Analysis
  • 8.3. Hospitals and Clinics Historic and Forecast Sales By Regions
  • 8.4. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
  • 8.5. Other End Users Historic and Forecast Sales By Regions

9. GLOBAL EMBOLOTHERAPY MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE EMBOLOTHERAPY COMPANIES

  • 10.1. Embolotherapy Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF EMBOLOTHERAPY INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Merit Medical Systems
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Boston Scientific Corporation
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Medtronic Plc
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Meril Life Sciences Pvt. Ltd
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Embolic agents Market Sales By Geography (USD MN)
  • Microspheres Market Sales By Geography (USD MN)
  • Embolic coils (Detachable Coils, Pushable Coils) Market Sales By Geography (USD MN)
  • Liquid Embolic Agents Market Sales By Geography (USD MN)
  • Embolic Plug Systems Market Sales By Geography (USD MN)
  • Detachable Balloons Market Sales By Geography (USD MN)
  • Support Devices Market Sales By Geography (USD MN)
  • Microcatheters Market Sales By Geography (USD MN)
  • Guidewires Market Sales By Geography (USD MN)
  • Analysis By Disease Indication (USD MN)
  • Cancer Market Sales By Geography (USD MN)
  • Liver Cancer Market Sales By Geography (USD MN)
  • Kidney Cancer Market Sales By Geography (USD MN)
  • Other Cancers Market Sales By Geography (USD MN)
  • Peripheral Vascular Diseases Market Sales By Geography (USD MN)
  • Neurological Diseases Market Sales By Geography (USD MN)
  • Cerebral Aneurysm Market Sales By Geography (USD MN)
  • Cerebral Arteriovenous Malformations and Fistulas Market Sales By Geography (USD MN)
  • Gastrointestinal Disorders Market Sales By Geography (USD MN)
  • Urological and Nephrological Disorders Market Sales By Geography (USD MN)
  • Analysis By Procedure Analysis (USD MN)
  • Transcatheter Arterial Embolization Market Sales By Geography (USD MN)
  • Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy Market Sales By Geography (USD MN)
  • Transarterial Chemoembolization Market Sales By Geography (USD MN)
  • Analysis By End User Analysis (USD MN)
  • Hospitals and Clinics Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Other End Users Market Sales By Geography (USD MN)
  • Global Embolotherapy Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Embolotherapy Report
  • Market Research Process
  • Market Research Methodology
  • Global Embolotherapy Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Disease Indication
  • Market Attractiveness Analysis By Procedure Analysis
  • Market Attractiveness Analysis By End User Analysis
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Embolic agents Market Sales By Geography (USD MN)
  • Microspheres Market Sales By Geography (USD MN)
  • Embolic coils (Detachable Coils, Pushable Coils) Market Sales By Geography (USD MN)
  • Liquid Embolic Agents Market Sales By Geography (USD MN)
  • Embolic Plug Systems Market Sales By Geography (USD MN)
  • Detachable Balloons Market Sales By Geography (USD MN)
  • Support Devices Market Sales By Geography (USD MN)
  • Microcatheters Market Sales By Geography (USD MN)
  • Guidewires Market Sales By Geography (USD MN)
  • Global Market Analysis By Disease Indication (USD MN)
  • Cancer Market Sales By Geography (USD MN)
  • Liver Cancer Market Sales By Geography (USD MN)
  • Kidney Cancer Market Sales By Geography (USD MN)
  • Other Cancers Market Sales By Geography (USD MN)
  • Peripheral Vascular Diseases Market Sales By Geography (USD MN)
  • Neurological Diseases Market Sales By Geography (USD MN)
  • Cerebral Aneurysm Market Sales By Geography (USD MN)
  • Cerebral Arteriovenous Malformations and Fistulas Market Sales By Geography (USD MN)
  • Gastrointestinal Disorders Market Sales By Geography (USD MN)
  • Urological and Nephrological Disorders Market Sales By Geography (USD MN)
  • Global Market Analysis By Procedure Analysis (USD MN)
  • Transcatheter Arterial Embolization Market Sales By Geography (USD MN)
  • Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy Market Sales By Geography (USD MN)
  • Transarterial Chemoembolization Market Sales By Geography (USD MN)
  • Global Market Analysis By End User Analysis (USD MN)
  • Hospitals and Clinics Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Other End Users Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.